This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20170119 PLA WGM"
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 38: | Line 38: | ||
===============================================================================---> | ===============================================================================---> | ||
|- | |- | ||
| − | | || Calvin Beebe | + | | x|| Calvin Beebe |
|- | |- | ||
| ||Lorraine Constable | | ||Lorraine Constable | ||
| Line 44: | Line 44: | ||
| || Jean Duteau, | | || Jean Duteau, | ||
|- | |- | ||
| − | | || Tony Julian | + | |x || Tony Julian |
|- | |- | ||
| − | | || Paul Knapp | + | |x || Paul Knapp |
|- | |- | ||
| − | | || Austin Kreisler, | + | |x|| Austin Kreisler, |
|- | |- | ||
| − | | || | + | |x || Anne Wizauer |
|- | |- | ||
| − | | || Mary Kay McDaniel | + | |x || Mary Kay McDaniel |
|- | |- | ||
| || Brian Pech | | || Brian Pech | ||
| Line 80: | Line 80: | ||
===Minutes=== | ===Minutes=== | ||
| − | + | *Updates from the week: | |
| − | + | **Austin gave an update to TSC on progress | |
| − | + | **Discussion over future of V3 issues – vague discussion at TSC regarding potential V3 product family. | |
| + | **CDAMG: Proposed M&C will go to TSC in Madrid. CDAMG will hold first WGM meeting in September. Group is separate from Structured Docs. Discussion over tension between clinical domains and technical committees. Mix of management bodies – need implementers representing stakeholders, provider perspective, payer perspective. Would be nice to have a nurturer and a project manager in the mix who could bring things together. Technical bodies often lack business knowledge. Currently we have SGB chair, CTO, four SD members, one international… | ||
| + | **Austin: Need to focus on roles and fill that way. Discussion over type of representation that could potentially come from SDs. Need to remember it’s an international standard base. MK displays structure section in M&C. Roles: PM, Negotiator/nurturer, provider, payer, implementer, international, sampling of domain committees, sampling of the steering committees. | ||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
| Line 100: | Line 102: | ||
* | * | ||
| + | |- | ||
| + | <!---======================================================================= | ||
| + | | | | ||
| + | | NN NN EEEEEE XX XX TTTTTT MM MM TTTTTT GGGGG | | ||
| + | | NNN NN EE XX XX TT MMM MMM TT GG | | ||
| + | | NN NN NN EEEE XXX TT MM MMM MM TT GG GGG | | ||
| + | | NN NNN EE XX XX TT MM M MM TT GG GG | | ||
| + | | NN NN EEEEEE XX XX TT MM MM TT GGGGG | | ||
| + | | | | ||
| + | ========================================================================---> | ||
| + | |||
| + | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
| + | *[[20170208 PLA call]] | ||
|} | |} | ||
© 2017 Health Level Seven® International. All rights reserved | © 2017 Health Level Seven® International. All rights reserved | ||
Latest revision as of 16:44, 8 February 2017
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes Location: Blanco |
Date: 2016-01-20 Time: 8:00 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| x | Calvin Beebe | ||
| Lorraine Constable | |||
| Jean Duteau, | |||
| x | Tony Julian | ||
| x | Paul Knapp | ||
| x | Austin Kreisler, | ||
| x | Anne Wizauer | ||
| x | Mary Kay McDaniel | ||
| Brian Pech | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
- Agenda review
- Updates from the week
Minutes
- Updates from the week:
- Austin gave an update to TSC on progress
- Discussion over future of V3 issues – vague discussion at TSC regarding potential V3 product family.
- CDAMG: Proposed M&C will go to TSC in Madrid. CDAMG will hold first WGM meeting in September. Group is separate from Structured Docs. Discussion over tension between clinical domains and technical committees. Mix of management bodies – need implementers representing stakeholders, provider perspective, payer perspective. Would be nice to have a nurturer and a project manager in the mix who could bring things together. Technical bodies often lack business knowledge. Currently we have SGB chair, CTO, four SD members, one international…
- Austin: Need to focus on roles and fill that way. Discussion over type of representation that could potentially come from SDs. Need to remember it’s an international standard base. MK displays structure section in M&C. Roles: PM, Negotiator/nurturer, provider, payer, implementer, international, sampling of domain committees, sampling of the steering committees.
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
